Sabina Rinaldi
YOU?
Author Swipe
View article: Data from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Data from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Open
Background:Obesity is a risk factor for endometrial cancer but whether metabolic dysfunction is associated with endometrial cancer independent of body size is not known.Methods:The association of metabolically defined body size phenotypes …
View article: Data from Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort
Data from Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort Open
Background:Case–control studies show that copper (Cu) is high and zinc (Zn) low in blood and urine of women with breast cancer compared with controls.Methods:To assess whether prediagnostic Cu and Zn are associated with breast cancer risk,…
View article: Data from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis
Data from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis Open
Background:Endogenous sex hormones may contribute to higher colorectal cancer incidence rates in men compared with women, but despite an increased number of studies, clear evidence is lacking.Methods:We conducted a comprehensive nested cas…
View article: Supplementary Table from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis
Supplementary Table from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis Open
Supplementary Table from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis
View article: Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Open
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
View article: Supplementary Table from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis
Supplementary Table from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis Open
Supplementary Table from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis
View article: Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Open
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
View article: Supplementary Figure from Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort
Supplementary Figure from Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort Open
Supplementary Figure from Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort
View article: Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Open
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
View article: Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Open
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
View article: Supplementary Data from Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort
Supplementary Data from Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort Open
Supplementary Data from Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort
View article: Supplementary Table from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis
Supplementary Table from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis Open
Supplementary Table from Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case–Control Study and Meta-Analysis
View article: Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Open
Supplementary Table from Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
View article: Prospective evaluation of circulating plasma thyroid hormones concentrations and breast cancer risk in the EPIC cohort
Prospective evaluation of circulating plasma thyroid hormones concentrations and breast cancer risk in the EPIC cohort Open
This work was funded by the French National Cancer Institute (grant number 2018-118).
View article: Large-scale association analysis identified novel differentiated thyroid carcinoma risk loci by integrating transcriptome and proteome
Large-scale association analysis identified novel differentiated thyroid carcinoma risk loci by integrating transcriptome and proteome Open
View article: Body mass index and breast cancer risk among postmenopausal women with and without cardiometabolic diseases: Findings from two prospective cohort studies in Europe
Body mass index and breast cancer risk among postmenopausal women with and without cardiometabolic diseases: Findings from two prospective cohort studies in Europe Open
Background Adiposity, measured by body mass index (BMI), is a known risk factor for postmenopausal breast cancer. However, whether the association of BMI with breast cancer risk differs among women with and without cardiovascular diseases …
View article: Association Between Dietary Intake and Blood Concentrations of One-Carbon-Metabolism-Related Nutrients in European Prospective Investigation into Cancer and Nutrition
Association Between Dietary Intake and Blood Concentrations of One-Carbon-Metabolism-Related Nutrients in European Prospective Investigation into Cancer and Nutrition Open
Background/Objectives: We examined the association between dietary intake and blood concentrations of one-carbon metabolism (OCM)-related nutrients in the European Prospective Investigation into Cancer and Nutrition (EPIC). Methods: Blood …
View article: Table S1 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S1 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Minimum, median and maximum values of the quartiles of normalized biomarker concentrations
View article: Figure S3 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Figure S3 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Figure S3 illustrates the assumed relationships between insulin, c-peptide, IGF-1, IGFBP-3, postmenopausal ER-positive breast cancer, and sociodemographic and lifestyle factors.
View article: Table S10 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S10 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Risk ratios and 95% confidence intervals of postmenopausal estrogen-receptor positive breast cancer per doubling biomarker concentration and by quartiles of biomarker concentration, excluding self-reported diabetics and users of oral hypog…
View article: Data from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Data from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Background:Higher concentration of insulin-like growth factor-1 (IGF-1) increases postmenopausal breast cancer risk, but evidence for insulin and c-peptide is limited. Furthermore, not all studies have accounted for potential confounding b…
View article: Table S3 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S3 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Geometric mean ratios for biomarkers in relation to body mass index
View article: Table S9 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S9 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Risk ratios and 95% confidence intervals of postmenopausal estrogen-receptor positive breast cancer per doubling biomarker concentration and by quartiles of biomarker concentration, excluding cases and deaths that occurred within one year …
View article: Table S8 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S8 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Risk ratios and 95% confidence intervals of postmenopausal estrogen-receptor positive breast cancer per doubling biomarker concentration and by quartiles of biomarker concentration, additionally adjusted for estradiol and sex-hormone bindi…
View article: Table S4 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S4 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Geometric means of biomarkers by measured covariates
View article: Table S7 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S7 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Estimated residual intra-class correlation coefficients for the total proportion of variation attributable to batch
View article: Table S6 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S6 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Estimated intra-batch and inter-batch reliability intra-class correlation coefficients from analysis of quality control samples
View article: Table S2 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S2 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Pearson correlation coefficients of biomarkers in the subcohort
View article: Figure S1 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Figure S1 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Figure S1 presents scatter plots of quality control samples for insulin (Panel A), c-peptide (Panel B), IGF-1 (Panel C) and IGFBP-3 (Panel D) by batch.
View article: Table S11 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis
Table S11 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis Open
Risk ratios and 95% confidence intervals of postmenopausal estrogen-receptor positive breast cancer per doubling biomarker concentration and by quartiles of biomarker concentration, excluding tumors of unknown or estrogen receptor-negative…